• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Discounting life-years: whither time preference?

作者信息

Gyrd-Hansen D, Søgaard J

机构信息

Center for Health and Social Policy, Odense University, Denmark.

出版信息

Health Econ. 1998 Mar;7(2):121-7. doi: 10.1002/(sici)1099-1050(199803)7:2<121::aid-hec318>3.0.co;2-h.

DOI:10.1002/(sici)1099-1050(199803)7:2<121::aid-hec318>3.0.co;2-h
PMID:9565168
Abstract

If elicited time preferences are to be incorporated into economic evaluations, not only social but also individual preferences may be included. The view of this paper is that social intertemporal preferences should govern social intertemporal choices when prioritising between the saving of lives now or in the future. However, the present value of an individual's stream of future health benefits is a matter of private consumption and hence either individual time preferences or social interpersonal preferences could be applied when evaluating the value of extended life or improved quality of life. This paper shows that it is possible to incorporate both types of time preferences in an economic evaluation; using the individual time preference or the social interpersonal preference when discounting the remaining life expectancy and the social intertemporal time preference for discounting the health benefits from the time of the risk reduction to present time. Such a scenario could solve potential problems such as double discounting of QALYs, the paradox of intertemporal equity versus interpersonal equity, as well as include elements of quantity, risk and uncertainty which are otherwise ignored in evaluations of life-saving therapies.

摘要

相似文献

1
Discounting life-years: whither time preference?
Health Econ. 1998 Mar;7(2):121-7. doi: 10.1002/(sici)1099-1050(199803)7:2<121::aid-hec318>3.0.co;2-h.
2
Measuring the social importance of concentration or dispersion of individual health benefits.衡量个体健康效益集中或分散的社会重要性。
Health Econ. 2002 Jan;11(1):43-53. doi: 10.1002/hec.643.
3
Discounting in health care decision-making: time for a change?医疗保健决策中的贴现:是时候做出改变了吗?
J Public Health Med. 1992 Sep;14(3):250-6.
4
Double discounting of QALYs.质量调整生命年的双重贴现
Health Econ. 2003 Feb;12(2):165-9. doi: 10.1002/hec.718.
5
Comparing the results of applying different methods of eliciting time preferences for health.比较应用不同方法引出健康时间偏好的结果。
Eur J Health Econ. 2002;3(1):10-6. doi: 10.1007/s10198-002-0098-5.
6
Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?消费与健康的生命周期偏好:成本效益分析何时等同于成本效益分析?
J Health Econ. 1999 Dec;18(6):681-708. doi: 10.1016/s0167-6296(99)00014-4.
7
Valuing future benefits.重视未来收益。
Health Econ. 1994 Jul-Aug;3(4):221-9. doi: 10.1002/hec.4730030404.
8
The importance of perspective in the measurement of quality-adjusted life years.视角在质量调整生命年测量中的重要性。
Med Decis Making. 1997 Jan-Mar;17(1):33-41. doi: 10.1177/0272989X9701700104.
9
Inquiry into the relationship between equity weights and the value of the QALY.探究股权权重与 QALY 值之间的关系。
Value Health. 2012 Dec;15(8):1119-26. doi: 10.1016/j.jval.2012.07.002. Epub 2012 Sep 25.
10
Improving value measurement in cost-effectiveness analysis.提高成本效益分析中的价值衡量
Med Care. 2000 Sep;38(9):892-901. doi: 10.1097/00005650-200009000-00003.

引用本文的文献

1
Length of time periods in treatment effect descriptions and willingness to initiate preventive therapy: a randomised survey experiment.治疗效果描述中时间段的长度和预防性治疗的意愿:一项随机调查实验。
BMC Med Inform Decis Mak. 2018 Nov 20;18(1):106. doi: 10.1186/s12911-018-0662-2.
2
Nonparametric restricted mean analysis across multiple follow-up intervals.跨多个随访间隔的非参数受限均值分析。
Stat Probab Lett. 2016 Feb 1;109:152-158. doi: 10.1016/j.spl.2015.11.014.
3
Nonparametric tests of treatment effect based on combined endpoints for mortality and recurrent events.
基于死亡率和复发事件综合终点的治疗效果非参数检验。
Biostatistics. 2015 Jan;16(1):73-83. doi: 10.1093/biostatistics/kxu013. Epub 2014 Apr 8.
4
Using discounting biases, risk characteristics, and perceived control improves preventive programs.利用折扣偏差、风险特征和感知控制可改善预防计划。
Int J Biomed Sci. 2007 Jun;3(2):81-5.
5
Discounting health effects in pharmacoeconomic evaluations: current controversies.药物经济学评价中对健康影响的贴现:当前争议
Pharmacoeconomics. 2005;23(7):639-49. doi: 10.2165/00019053-200523070-00001.
6
Willingness to pay for a QALY: theoretical and methodological issues.支付意愿以获取一个质量调整生命年:理论与方法学问题。
Pharmacoeconomics. 2005;23(5):423-32. doi: 10.2165/00019053-200523050-00002.
7
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases.通过经济评估重视预防:关于健康影响贴现模型选择的一些考量,重点关注传染病
Pharmacoeconomics. 2004;22(18):1171-9. doi: 10.2165/00019053-200422180-00002.
8
Theoretical arguments for the discounting of health consequences: where do we go from here?健康后果贴现的理论依据:我们将何去何从?
Pharmacoeconomics. 2002;20(14):943-61. doi: 10.2165/00019053-200220140-00001.
9
The cost to society of smoking cessation.戒烟对社会的成本。
Thorax. 1998 Aug;53 Suppl 2(Suppl 2):S38-42. doi: 10.1136/thx.53.2008.s38.